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Diabetic muscle infarction: a rare end-organ vascular complication of diabetes 
 
Abstract 
Diabetic muscle infarction (DMI) is a rare microvascular complication of spontaneous ischemic 
necrosis of skeletal muscle in patients with poorly controlled diabetes. We herein describe the 
case of a 26-year-old woman with a history of type I diabetes and accompanying diabetic 
microvascular complications of neuropathy, nephropathy and retinopathy, who presented with 
sudden onset of swelling and sharp pain in her bilateral thighs. T2-weighted MRI imaging 
revealed subcutaneous edema and sub-fascial, hyper-intense enhancement of proximal thigh 
musculature. DMI has a relatively non-specific clinical presentation; therefore, physician 
awareness is key for early diagnosis, as aggressive management has been associated with poor 
patient outcomes. With poor long-term prognosis and high reoccurrence, DMI acts as an 
indicator of vascular end-organ damage. 
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Introduction 
Diabetic muscle infarction (DMI) is a rare microvascular complication consisting of spontaneous 
ischemic necrosis of skeletal muscle in patients with poorly controlled diabetes. Though its 
characteristics have been defined, fewer than 200 cases1,2 have been reported since it was first 
described in 1965 by Angervall and Stener.3 Originally, it was termed “tumoriform focal 
muscular degeneration,” owing to the initial cases’ resemblance to tumors, which in that case 
were completely excised.1,3-7 The condition has also known as diabetic, aseptic, or ischemic 
myonecrosis. 
DMI can occur in patients with either type 1 or 2 diabetes, with type 1 representing around 70% 
of cases.7-10 Affected patients have a history of long-standing (>15 years) and poorly controlled 
diabetes (average Hgb a1c of 9.4% with a range of 5.0% to 12.4%),2,4,5,9-16 with a mean age of 43 
years old at diagnosis1,5-7,9,13,16,17 and mean duration between diagnosis of diabetes and DMI 
around 14.4 years.5,7,10,13,17 There seems to be a slight predilection towards females.1,5,7,11,13 
Nearly 97%9,13 of patients present with end-organ diabetic microvascular complications7,11,14 
including nephropathy (57%), retinopathy (71%) and neuropathy (55%).4-7,16,17  
Due to the rarity of the disease and many alternative etiologies for the symptoms, DMI is often 
under-recognized, leading to delayed diagnosis, inappropriate treatment, and excessive lab and 
radiographic testing.5,6,8,10 In this case, a 26-year-old woman with type 1 diabetes mellitus 
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Case Presentation 
At 26 years of age, a non-smoking type 1 diabetic patient with neuropathy, nephropathy, and 
retinopathy presented to her primary care physician from a local emergency room with a seven-
day history of sudden swelling followed by a sharp pain in her bilateral thighs that initially 
occurred during a hike in the woods. The pain was constant and limited her range of motion, 
making ambulation difficult. No erythema, focal warmth or masses were appreciable. Her vital 
signs were stable, and she was afebrile. Her white blood cell count was 9.9 k/mm3 (range: 5-10 
k/mm3) with 82.4% neutrophils. The chemistry profile demonstrated a creatinine of 3.6 mg/dL 
and glucose of 157 mg/dL. Hgb a1c was 10.4% (normal: < 7%). Erythrocyte sedimentation rate 
(ESR) was elevated at 140 mm/hr (normal: 0-20 mm/hr), as were creatine phosphokinase (CPK) 
and serum myoglobin at 259 U/L (normal: 30-135 U/L) and 413 ng/dL (normal: 0-110 ng/dL) 
respectively. D-dimer was positive at 5.1 mg/L (normal: 0.200-2.18 mg/L), but her subsequent 
venous ultrasound ruled out lower extremity deep venous thrombosis (DVT). A presumptive 
diagnosis of cellulitis was initially given, and she was treated with ciprofloxacin. 
 
One week later, as the pain and edema increased, she was no longer ambulatory despite 
improving ESR (109 mm/hr), CPK (151 U/L) and myoglobin (280 ng/dL). T2-weighted MRI 
images showed diffuse subcutaneous edema as well as sub-fascial and hyperintense enhancement 
of the adductor brevis, magnus, and longus. Some involvement of the upper gracilis was also 
noted, and the patient was placed on bed rest. Two weeks later, she was hospitalized for acute 
renal failure, but her painful, edematous thighs persisted. Upon admission her ESR was 40 
mm/hr, CPK was 74 U/L, and myoglobin was 214 ng/dL. Swelling and pain persisted throughout 
that and a second admission for acute renal failure. Because of the probable diagnosis of DMI, a 
muscle biopsy was not performed. With the treatment of only bed rest, pain control with non-
steroidal anti-inflammatory medications (NSAIDs) and narcotics, symptoms resolved 
spontaneously within six weeks. Table 1 demonstrates the patient’s demographic and clinical 
parameters compared to the accumulated ranges reported in the literature. 
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Diabetic Myonecrosis Trends & Comparison to Case Patient 
Demographics Range Case Patient 
Gender 54%-66% Female Female 
Age 40-49 yo 26 yo 
Diabetes, type 1 41.5%-75% Yes 
Hgb a1c 5.0-12.4% 10.4 
Years since Diabetes Diagnosed 14.4-17 years 17 years 
Diabetes Complications 97% Yes 
Nephropathy 57%-71% Yes 
Retinopathy 57%-71% Yes 
Neuropathy 55%-75% Yes 
Symptoms 
Acute Universal Yes 
Local Swelling 75.6%-99% Yes 
Tenderness 80%-100% Yes 
Palpable Mass 33.7%-44% No 
Lack of Fever 89% Yes 
Limited ROM Worse with movement Yes 
Erythema Not Common No 
Edema Common Yes 
Unilateral 60%-91.6% Bilateral 
Proximal 66.7%-87% Yes 
Muscle Groups 
Quadriceps 60%-87% No 
Hip Adductors 13% Yes 
Hamstrings 8% No 
Hip Flexors 2% No 
Calf 13%-22.9% No 
Multiple 39% Multiple 
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Diagnosis 
Erythrocyte Sedimentation Rate increased 31.4%-88.9% 140 
Creatinine Phosphokinase increased 81.8%-90% 259 
Myoglobin increased 81.8%-90% 413 
White Blood Cells increase 8%-56.6% 9.94 
Blood Culture Negative Negative 
Ultrasound Useful to rule out DVT ruled out DVT 
T2-Weighted MRI 
Hyperintense = necrosis, edema & subfascial 
fluid 
Hyperintense 
Muscle Biopsy Monocytic infiltration, necrosis, and fibrosis Not Done 
Prognosis 
Resolution 6 to 8 weeks 9 weeks 
Recurrence 40-50% Did not recur 
Mortality 10% Mortality Rate within 2 years Died 7.5 months later 
Table 1: Denotes the consensus of demographics, signs and symptoms and diagnostic results of reported 
patients with diabetic muscle infarction and compares them to the case-patient. 
 
The patient’s chronic renal failure worsened, and within a month she was placed on peritoneal 
dialysis before having a simultaneous kidney-pancreas transplant four months later. Her 
postoperative course was complicated by an abdominal hematoma that needed to be evacuated. 
She also suffered a CVA with right-sided hemiparesis that led to seizures. Two and a half 
months from her transplant she succumbed to vancomycin-resistant enterococci (VRE) sepsis 
secondary to pneumonia and pyelonephritis. 
 
Discussion  
The findings suggestive of DMI in this patient begin with her spontaneous acute muscular pain, 
markedly in her thighs, with no history of trauma or indication of infection.1,2,5,7,9-11,15,18 The 
severe pain, even at rest, was exacerbated by movement, which limited her 
mobility.8,11,12,14,17,19,20 DMI usually presents unilaterally 4,10,18 in the proximal lower extremity 
(81-83%) with rare reports of distal leg involvement.2,5,8,11,14,19,20 Muscles commonly affected 
include quadriceps (60%),4,10,16,18 hip adductors (13%),4,10,11,14,16 hamstrings (8%)4,10,16,18 and hip 
flexors (2%).4,10,16 Patients are typically afebrile, without skin discoloration,9,11,20 and usually 
present with accompanying local swelling (90%- 99%),1,2,4,5,7-13,16-20 tenderness,1,2,4-10,12,13,15-19 
and painful, palpable mass (44%).2,6,7,9,11-14,17-20 
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DMI is frequently misdiagnosed because of the significant overlap of its clinical features with 
other life- and limb-threatening etiologies, and there remains no clear consensus of diagnostic 
criteria.1,6,15 Differential diagnoses considerations are extensive (Table 2). Currently, diagnosis 
of DMI consists of a clinical assessment and MRI.5-7,19 Muscle biopsies, revealing some 
combination of monocytic inflammation, hemorrhagic necrosis, fibrosis, atrophy, and 
neovascularization, are the gold standard, carrying 90% sensitivity and 95% sensitivity19, and are 
not recommended because of procedural complications, including delayed healing and 
infection.1,2,4-7,10,15,16,19 If attempted, a minimally invasive approach is recommended, which 
should be reserved for patients with an atypical presentation, uncertain diagnosis, or those that do 
not improve with treatment.2,7,15,19  
Diabetic Muscle Infarction Differential Diagnoses  
     
Table 2: Categorization of the diagnoses in the differential for diabetic muscle infarction. (DVT = deep 
venous thrombosis. Diabetic amyotrophy is also known as diabetic lumbosacral radiculoplexus 
neuropathy, proximal diabetic neuropathy, and diabetic polyradiculoneuropathy) 
Infectious Inflammatory Malignancy Musculoskeletal Vascular 





















Sarcoma Muscle Rupture Thrombophlebitis 
Parasitic Infection Statin-Induced Vasculitis 
Trauma 
  
MRI with T2-weighted imaging is the most valuable diagnostic imaging method, carrying a 
sensitivity close to 100%,1,2,6,8-11,13,15,17,19 with hyperintense images of subfascial fluid from 
edema and hemorrhage with enlargement of defined muscles (Picture 1).2,4,5,7,10,11,13,14,20 This 
contrasts with T1-weighted images, which would show water content from edema and water 
content as hypointense.2,7,10,13,15,20 Other radiographic techniques, such as ultrasound and CT, are 
not considered satisfactory to confirm the diagnosis but are useful for excluding other 
disorders.7,9 In contrast to imaging, there is a lack of consistency in lab findings.5-7,10 White 
blood cell counts, CPK levels, and inflammatory markers may be normal to elevated.2,6,7,9,14,15,18 
It is suggested CPK is elevated during the early presentation and falls to normal levels later in 
the disease course.17 Patients’ delay in seeking medical attention, approximately four weeks on 
average, may prevent the detection of these changes and likely account for the variation of 
finding in the literature.5,7 Table 3 demonstrates the laboratory and physical exam variations in 
the case-patient. This trend seems to correlate with the variability of a necrosis-reperfusion 
process and has not yet been explored in the literature.  
32
Seaman et al.: Diabetic Muscle Infarction
Published by Marshall University's Joan C. Edwards School of Medicine, 2019
 
Picture 1: Proton density fat-saturated MRI showing increased signal within the 
semimembranosus, biceps femoris, and adductor magnus musculature that is found to be 
consistent with edema due to early muscle infarction.1 
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Case Patient Lab Trends and Physical Exam Findings 
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Table 3: Comparison of the trend in lab work for the case patient over time in relation to 
symptoms. (WBC = white 
blood count, ESR = erythrocyte sedimentation rate, CPK = creatinine 
phosphokinase)   
 
The literature predominately laments that the pathophysiology of DMI is not well understood, 
and more research is needed.1,2,5,8-10,12 Patient history, clinical presentation, histological features, 
and radiographic imaging seem to point to a unifying theory of a microangiopathic vascular 
complication.1,5,7,9-12,15,16,18,19 A cascade initiated by microvascular endothelial damage leads to 
tissue ischemia activating inflammatory cascade causing local tissue damage. This damage is 
followed by the focal replacement of the infarcted muscle with collagen (Picture 2). Reperfusion 
occurs, resulting in impaired endothelial-dependent dilation of arterioles, increased oxygen 
radicals, and decreased nitric oxide leading to further injury.1,5,11 Increased edema creates intra-
compartmental pressure, decreasing blood flow further creating ischemia from compartment 
syndrome.1,5,7,17 Muscle regeneration occurs as well and may be seen histologically at time of 
care.11 
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Picture 2: Histologic Slide of a Diabetic Muscle Infarction biopsy under H&E stain. Macrocytic 
invasion is seen along with the collagenous replacement of infarcted tissue.4  
  
Early recognition of DMI is important to avoid inappropriate treatment.2,5,10,11,17 Current 
recommendations are based on limited evidence1,19 and consist mainly of supportive care,4,5,8-
10,13-16,18,20 including bed rest combined with aspirin and NSAIDS.1,2,4,6-11,13-18,20 Perhaps the most 
important intervention, however, is rigorous glycemic control. Hyperglycemia may contribute to 
DMI by affecting the remodeling of vasculature, platelet function, and coagulation factors.6 
Surgical intervention is not recommended and has shown poor outcomes with increased recovery 
time, risk of infection, hematoma, nerve palsy, sepsis, and compartment syndrome.1,4,8,10,15,17,20 
Physical therapy should be avoided in the acute phase as muscle stretching can increase pain and 
swelling, ultimately prolonging recovery, but may have a place in care following the acute 
injury.1,5-8,14,17 
One should view the prognosis rates as similar to a patient with a myocardial infarction.2 Short-
term prognosis of the patients is good, and a majority make a full recovery with spontaneous 
resolution of symptoms within weeks to months.2,5,9,10,17 However, patients are at high risk of 
reoccurrence (~50%),1,12 within the original muscle (8.7%)7,9 or a different muscle group 
(40%).8,10,16 Unfortunately, the long-term prognosis is poor, as most patients die within 2-5 years 
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of diagnosis.2,6,7,9,10 The presence of DMI acts as an indicator suggestive of end-organ 
vasculopathy, and patients should undergo evaluation for other vascular damage.9 
Conclusion 
The overall literature on DMI is small and the publications have a significant overlap in findings. 
While the prevailing principles for presentation, diagnosis, and management are in general 
agreement, the small individual cohorts lend themselves to wide variability in specific 
percentages. Making sense of proper diagnostic and management principles is important, as more 
aggressive options have deleterious effects. Clearly, overall, DMI is a harbinger of vascular end-
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